
Sanofi’s Dupixent Shows Strong Efficacy in Second Lung Trial
Sanofi’s prescription drug Dupixent showed additional promise in helping patients with a chronic lung disorder breathe better and
1970-01-01 08:00

Sanofi Taps Adviser for OTC Spinoff as Buyout Firms Circle
Sanofi is working with an adviser to start preparations for a planned separation of its consumer health division,
1970-01-01 08:00

Sanofi Probed for Market Manipulation by French Authorities
French financial prosecutors are investigating Sanofi for alleged market manipulation. The preliminary probe opened in March involves alleged
1970-01-01 08:00

Sanofi Warning Outweighs Spinoff, Prompting €19.5 Billion Plunge
Sanofi shares plunged after a surprise forecast for lower profit next year overshadowed optimism about a plan to
1970-01-01 08:00

Sanofi Plans to Split Off Consumer Health Unit to Narrow Focus
Sanofi said it plans to separate its consumer health division, probably through a spinoff, as the French drugmaker
1970-01-01 08:00

Sanofi to Explore Acquisition of Cancer Drugmaker Mirati
French pharmaceutical giant Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc., according to people
1970-01-01 08:00

Sanofi Was Mystery Bidder That Lost Reata to Biogen
Biogen Inc. narrowly beat out Sanofi SA to clinch its $7.3 billion acquisition of Reata Pharmaceuticals, according to
1970-01-01 08:00

AstraZeneca, Sanofi RSV Drug for Infants Wins CDC Backing
A drug from AstraZeneca Plc and Sanofi to protect infants against a potentially fatal respiratory illness won backing
1970-01-01 08:00

Sanofi Lifts Guidance on Dupixent, Covid Vaccine Sales
Sanofi raised its forecast for the year as the French drugmaker gains new patients for blockbuster drug Dupixent
1970-01-01 08:00

LVMH to Sponsor Paris Olympics in a First for Luxury Group
LVMH agreed to become a premium sponsor of the 2024 Summer Olympics in Paris in the first deal
1970-01-01 08:00

Astra, Sanofi RSV Drug Approved in US for Use in Infants
AstraZeneca Plc and Sanofi’s drug for RSV in infants was approved in the US, the first-ever preventive intended
1970-01-01 08:00

Sanofi Cuts Zantac Exposure With Arbitration Win Over Boehringer
Sanofi defeated Boehringer Ingelheim GmbH in an arbitration proceeding over legal responsibilities tied to controversial heartburn medicine Zantac.
1970-01-01 08:00